Skip to main content

Military Health System

Utility Navigation Links

Need larger text?
TRICARE Policy Manual 6010.60-M, April 1, 2015
Medicine
Chapter 7
Section 2.6
Chelation Therapy
Issue Date:  October 12, 1984
Authority:  32 CFR 199.4(c)(2)(iii), (d)(3)(vi), and (g)(15)
Copyright:  CPT only © 2006 American Medical Association (or such other date of publication of CPT). All Rights Reserved.
Revision:  C-1, March 10, 2017
1.0  CPT PROCEDURE CODE
90784
2.0  DESCRIPTION
Chelation techniques for the therapeutic or preventive effects of removing unwanted metal ions from the body.
3.0  POLICY
Chelation therapy is covered if the chelator is U.S. Food and Drug Administration (FDA) approved and the therapy is for an FDA approved indication.
4.0  EXCLUSIONS
Chelation therapy (or chemical endarterectomy) is considered an unproven therapeutic modality for the treatment of the following conditions, and is not covered:
•  Multiple sclerosis
•  Arthritis
•  Hypoglycemia
•  Diabetes
•  Arteriosclerosis
•  Malaria
•  Cancer
•  Alzheimer’s disease
•  Autism spectrum disorders
•  Other off-label uses of FDA approved chelating agents.
- END -
You are leaving Health.mil The appearance of hyperlinks does not constitute endorsement by the Defense Health Agency of non-U.S. Government sites or the information, products, or services contained therein. Although the Defense Health Agency may or may not use these sites as additional distribution channels for Department of Defense information, it does not exercise editorial control over all of the information that you may find at these locations. Such links are provided consistent with the stated purpose of this website. You are leaving Health.mil View the external links disclaimer.
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on Twitter Follow us on YouTube Sign up on GovDelivery